As of 2025-11-16, the EV/EBITDA ratio of Cellectis SA (ALCLS.PA) is 19.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALCLS.PA's latest enterprise value is 276.26 mil EUR. ALCLS.PA's TTM EBITDA according to its financial statements is 14.37 mil EUR. Dividing these 2 quantities gives us the above ALCLS.PA EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 3.3x - 7.5x | 5.4x |
| Forward P/E multiples | 8.2x - 10.9x | 9.6x |
| Fair Price | 0.14 - 1.44 | 0.86 |
| Upside | -95.9% - -57.6% | -74.9% |
| Date | EV/EBITDA |
| 2025-11-07 | 16.83 |
| 2025-11-06 | 16.88 |
| 2025-11-05 | 17.09 |
| 2025-11-04 | 17.24 |
| 2025-11-03 | 17.21 |
| 2025-10-31 | 17.96 |
| 2025-10-30 | 17.81 |
| 2025-10-29 | 19.04 |
| 2025-10-28 | 18.01 |
| 2025-10-27 | 18.21 |
| 2025-10-24 | 17.49 |
| 2025-10-23 | 17.44 |
| 2025-10-22 | 18.06 |
| 2025-10-21 | 18.19 |
| 2025-10-20 | 18.64 |
| 2025-10-17 | 19.59 |
| 2025-10-16 | 22.88 |
| 2025-10-15 | 20.65 |
| 2025-10-14 | 21.30 |
| 2025-10-13 | 22.05 |
| 2025-10-10 | 20.55 |
| 2025-10-09 | 20.60 |
| 2025-10-08 | 21.95 |
| 2025-10-07 | 18.82 |
| 2025-10-06 | 17.51 |
| 2025-10-03 | 17.74 |
| 2025-10-02 | 16.91 |
| 2025-10-01 | 16.43 |
| 2025-09-30 | 14.33 |
| 2025-09-29 | 13.85 |
| 2025-09-26 | 17.46 |
| 2025-09-25 | 17.36 |
| 2025-09-24 | 17.89 |
| 2025-09-23 | 18.39 |
| 2025-09-22 | 18.36 |
| 2025-09-19 | 17.89 |
| 2025-09-18 | 16.38 |
| 2025-09-17 | 16.06 |
| 2025-09-16 | 16.08 |
| 2025-09-15 | 15.88 |
| 2025-09-12 | 15.96 |
| 2025-09-11 | 16.48 |
| 2025-09-10 | 15.48 |
| 2025-09-09 | 14.93 |
| 2025-09-08 | 14.63 |
| 2025-09-05 | 13.95 |
| 2025-09-04 | 13.78 |
| 2025-09-03 | 13.67 |
| 2025-09-02 | 13.57 |
| 2025-09-01 | 14.53 |